Baudax Bio (BXRX) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Baudax Bio (BXRX) Misses Q2 EPS by 1c

Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights

August 5, 2021 7:00 AM EDT

Total Number of ANJESO® Vials Sold to End-Users in the Second Quarter 2021 Match Total Vials Sold for the Full Year 2020

ANJESO® Demand Showing Strong Growth Based on Several Key Quarter-Over-Quarter Metrics (Second Quarter of 2021 Compared to First Quarter of 2021);

  Total Number of Vials Sold to All Customers Up 30%  Vials Sold to Hospitals and ASCs Combined Up 46%  Vials Sold to Existing Hospitals Up 55%  Vials Sold to New Ambulatory Surgery Centers Up 150%

Formulary Wins: 82% Success Rate at P&T... More